DELAWARE |
98-0181725 | |
(State or other jurisdiction of
incorporation or organization) |
(IRS Employer Identification
No.) | |
Global House Bailey
Lane Manchester United Kingdom |
M90 4AA | |
(Address of principal executive offices) |
(Zip Code) |
Class |
Outstanding as of October 31, 2002 | |
Common Stock, par value $0.01 |
11,842,744 |
September 30 2002 |
December 31 2001 | |||||
(Unaudited) |
||||||
(millions of dollars) | ||||||
ASSETS |
||||||
Current assets |
||||||
Cash and cash equivalents |
$ |
31.0 |
$ |
43.0 | ||
Accounts receivable, less allowance of $2.4 (2001$3.2) |
|
79.8 |
|
114.9 | ||
Other receivableVeritel |
|
9.6 |
|
22.4 | ||
Inventories |
||||||
Finished goods |
|
35.6 |
|
32.2 | ||
Raw materials and work-in-progress |
|
23.5 |
|
22.8 | ||
|
|
|
| |||
Total inventories |
|
59.1 |
|
55.0 | ||
Prepaid expenses |
|
3.9 |
|
3.0 | ||
|
|
|
| |||
Total current assets |
|
183.4 |
|
238.3 | ||
Property, plant and equipment |
|
103.0 |
|
76.5 | ||
Less accumulated depreciation |
|
32.6 |
|
9.6 | ||
|
|
|
| |||
Net property, plant and equipment |
|
70.4 |
|
66.9 | ||
Goodwill |
|
349.5 |
|
341.7 | ||
Intangible asset |
|
50.0 |
|
50.5 | ||
Deferred finance costs |
|
4.9 |
|
5.9 | ||
Prepaid pension cost |
|
96.7 |
|
82.4 | ||
Other assets |
|
4.3 |
|
3.0 | ||
|
|
|
| |||
$ |
759.2 |
$ |
788.7 | |||
|
|
|
|
September 30 2002 |
December 31 2001 |
|||||||
(Unaudited) |
||||||||
(millions of dollars) |
||||||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Current liabilities |
||||||||
Accounts payable (note 1) |
$ |
63.6 |
|
$ |
61.9 |
| ||
Other payableVeritel |
|
30.0 |
|
|
60.0 |
| ||
Accrued expenses (note 1) |
|
36.5 |
|
|
38.8 |
| ||
Accrued income taxes |
|
9.3 |
|
|
7.5 |
| ||
Current portion of long-term debt (note 1) |
|
56.8 |
|
|
65.1 |
| ||
Current portion of deferred income |
|
2.0 |
|
|
2.0 |
| ||
|
|
|
|
|
| |||
Total current liabilities |
|
198.2 |
|
|
235.3 |
| ||
Plant closure provisions (note 6) |
|
33.0 |
|
|
39.5 |
| ||
Deferred income taxes |
|
41.6 |
|
|
40.3 |
| ||
Long-term debt (note 1) |
|
112.7 |
|
|
165.9 |
| ||
Deferred income |
|
8.9 |
|
|
11.4 |
| ||
Minority interest |
|
5.2 |
|
|
5.9 |
| ||
Stockholders Equity |
||||||||
Common stock, $0.01 par value (note 2) |
|
0.1 |
|
|
0.1 |
| ||
Additional paid-in capital |
|
276.7 |
|
|
276.5 |
| ||
Treasury stock (note 2) |
|
(34.3 |
) |
|
(35.5 |
) | ||
Retained earnings |
|
160.2 |
|
|
106.4 |
| ||
Accumulated other comprehensive Income |
|
(43.1 |
) |
|
(57.1 |
) | ||
|
|
|
|
|
| |||
Total stockholders equity |
|
359.6 |
|
|
290.4 |
| ||
|
|
|
|
|
| |||
$ |
759.2 |
|
$ |
788.7 |
| |||
|
|
|
|
|
|
Three Months Ended September
30 |
Nine Months Ended September
30 |
|||||||||||||||
2002 |
2001 |
2002 |
2001 |
|||||||||||||
(millions of dollars except per share) |
||||||||||||||||
Net sales |
$ |
116.3 |
|
$ |
104.9 |
|
$ |
330.3 |
|
$ |
309.5 |
| ||||
Cost of goods sold (note 1) |
|
68.1 |
|
|
58.3 |
|
|
184.6 |
|
|
173.0 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Gross profit |
|
48.2 |
|
|
46.6 |
|
|
145.7 |
|
|
136.5 |
| ||||
Operating expenses |
||||||||||||||||
Selling, general and administrative |
|
15.9 |
|
|
15.0 |
|
|
47.8 |
|
|
40.3 |
| ||||
Research and development |
|
1.4 |
|
|
1.4 |
|
|
4.3 |
|
|
3.5 |
| ||||
Restructuring charge (note 1) |
|
3.1 |
|
|
0.3 |
|
|
3.1 |
|
|
1.6 |
| ||||
Amortization of goodwill |
|
|
|
|
11.6 |
|
|
|
|
|
34.6 |
| ||||
Amortization of intangible assets |
|
2.4 |
|
|
3.2 |
|
|
6.7 |
|
|
9.3 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
22.8 |
|
|
31.5 |
|
|
61.9 |
|
|
89.3 |
| |||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Operating income |
|
25.4 |
|
|
15.1 |
|
|
83.8 |
|
|
47.2 |
| ||||
Interest expense |
|
2.1 |
|
|
5.8 |
|
|
10.9 |
|
|
15.7 |
| ||||
Other expenses/(income) |
|
(0.8 |
) |
|
0.7 |
|
|
0.7 |
|
|
1.3 |
| ||||
Interest income |
|
(0.1 |
) |
|
(0.4 |
) |
|
(0.5 |
) |
|
(1.9 |
) | ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Income before income taxes and Minority interest |
|
24.2 |
|
|
9.0 |
|
|
72.7 |
|
|
32.1 |
| ||||
Minority interest |
|
0.5 |
|
|
1.3 |
|
|
2.1 |
|
|
2.7 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Income before income taxes |
|
23.7 |
|
|
7.7 |
|
|
70.6 |
|
|
29.4 |
| ||||
Income taxes (note 5) |
|
5.4 |
|
|
4.3 |
|
|
16.2 |
|
|
16.4 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Net income |
$ |
18.3 |
|
$ |
3.4 |
|
$ |
54.4 |
|
$ |
13.0 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Earnings per share: |
||||||||||||||||
Basic |
|
1.54 |
|
|
0.29 |
|
|
4.60 |
|
|
1.10 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Diluted |
|
1.44 |
|
|
0.27 |
|
|
4.32 |
|
|
1.04 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Weighted average shares outstanding (in thousands) |
||||||||||||||||
Basic (note 3) |
|
11,851 |
|
|
11,739 |
|
|
11,809 |
|
|
11,769 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Diluted (note 3) |
|
12,651 |
|
|
12,563 |
|
|
12,587 |
|
|
12,515 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September
30 |
||||||||
2002 |
2001 |
|||||||
(millions of dollars) |
||||||||
Cash Flows from Operating Activities |
||||||||
Net income |
$ |
54.4 |
|
$ |
13.0 |
| ||
Adjustments to reconcile net income to cash provided by operating activities: |
||||||||
Depreciation and amortization |
|
19.8 |
|
|
56.5 |
| ||
Deferred income taxes |
|
2.6 |
|
|
(1.1 |
) | ||
Other |
|
1.6 |
|
|
|
| ||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable and prepaid expenses |
|
41.0 |
|
|
17.6 |
| ||
Inventories |
|
(0.8 |
) |
|
14.1 |
| ||
Accounts payable and accrued expenses |
|
(16.0 |
) |
|
(16.2 |
) | ||
Income taxes and other current liabilities |
|
0.7 |
|
|
6.9 |
| ||
Other non-current assets and liabilities |
|
(19.0 |
) |
|
(5.4 |
) | ||
|
|
|
|
|
| |||
Net cash provided by operating activities |
|
84.3 |
|
|
85.4 |
| ||
Cash Flows from Investing Activities |
||||||||
Capital expenditures |
|
(8.2 |
) |
|
(3.6 |
) | ||
Business combinations, net of cash acquired |
|
(5.0 |
) |
|
(63.9 |
) | ||
Veritel |
|
(17.2 |
) |
|
|
| ||
Other |
|
(0.7 |
) |
|
|
| ||
|
|
|
|
|
| |||
Net cash used in investing activities |
|
(31.1 |
) |
|
(67.5 |
) | ||
Cash Flows from Financing Activities |
||||||||
Receipt of long-term borrowings |
|
24.7 |
|
|
|
| ||
Repayment of long-term borrowings |
|
(87.9 |
) |
|
(0.5 |
) | ||
Receipt of short-term credit |
|
1.4 |
|
|
|
| ||
Repurchase of common stock |
|
|
|
|
(3.1 |
) | ||
Dividends paid |
|
(0.6 |
) |
|
|
| ||
Proceeds on exercise of stock options |
|
0.2 |
|
|
|
| ||
Minority interest |
|
(0.7 |
) |
|
(0.7 |
) | ||
|
|
|
|
|
| |||
Net cash used in financing activities |
|
(62.9 |
) |
|
(4.3 |
) | ||
Effect of exchange rate changes on cash |
|
(2.3 |
) |
|
(7.5 |
) | ||
|
|
|
|
|
| |||
Net change in cash and cash equivalents |
|
(12.0 |
) |
|
6.1 |
| ||
Cash and cash equivalents at beginning of period |
|
43.0 |
|
|
37.7 |
| ||
|
|
|
|
|
| |||
Cash and cash equivalents at end of period |
$ |
31.0 |
|
$ |
43.8 |
| ||
|
|
|
|
|
|
Common Stock
|
Treasury Stock |
Additional Paid-In Capital |
Retained Earnings |
Other Comprehensive Income |
Total Comprehensive Income |
|||||||||||||||||
(millions of dollars) |
||||||||||||||||||||||
Balance at December 31, 2001 |
$ |
0.1 |
$ |
(35.5 |
) |
$ |
276.5 |
$ |
106.4 |
|
$ |
(57.1 |
) |
$ |
49.3 |
| ||||||
Net income |
|
|
|
|
|
|
|
|
54.4 |
|
|
|
|
|
54.4 |
| ||||||
Dividend ($0.05 per share) |
|
|
|
|
|
|
|
|
(0.6 |
) |
|
|
|
|
(0.6 |
) | ||||||
Derivatives(1) |
|
|
|
|
|
|
|
|
|
|
|
(1.8 |
) |
|
(1.8 |
) | ||||||
Net CTA(2) change |
|
|
|
|
|
|
|
|
|
|
|
15.8 |
|
|
15.8 |
| ||||||
Treasury stock issue |
|
|
|
1.2 |
|
|
0.2 |
|
|
|
|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Balance at September 30, 2002 |
$ |
0.1 |
$ |
(34.3 |
) |
$ |
276.7 |
$ |
160.2 |
|
$ |
(43.1 |
) |
$ |
117.1 |
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1) |
Unrealized gains/(losses) on derivative instruments |
2) |
Cumulative translation adjustment |
Reported |
FAS 142 |
Adjusted | |||||||
(Millions of dollars except per share) | |||||||||
Operating income |
$ |
47.2 |
$ |
35.7 |
$ |
82.9 | |||
Income before taxes |
|
29.4 |
|
34.6 |
|
64.0 | |||
Net income |
|
13.0 |
|
34.6 |
|
47.6 | |||
|
|
|
|
|
| ||||
Basic earnings per share |
$ |
1.10 |
$ |
2.94 |
$ |
4.04 | |||
|
|
|
|
|
| ||||
Diluted earnings per share |
$ |
1.04 |
$ |
2.76 |
$ |
3.80 | |||
|
|
|
|
|
|
1) |
Certain purchase accruals have been reclassified from accounts payable to accrued expenses, which management feels is more appropriate. The balance sheet at
December 31, 2001 has been restated by a transfer of $14.3 million to allow consistent comparison. |
2) |
The revolving bank credit facility has been reclassified from current portion to the long-term element of debt. The balance sheet at December 31, 2001 has been
restated by a transfer of $20.0 million to allow consistent comparison. |
3) |
Restructuring charges have been identified separately in the income statement. Prior year charges of $1.6 million, including third quarter $0.3 million, have
been reclassified from cost of goods sold to restructuring charges to allow consistent comparison. |
No. |
|||
Outstanding at June 30, 2002 |
1,539,253 |
| |
Exercised |
(7,248 |
) | |
Cancelled for payment |
(32,909 |
) | |
Cancelled |
(21,009 |
) | |
|
| ||
Outstanding at September 30, 2002 |
1,478,087 |
| |
|
|
Three Months Ended September
30 |
Nine Months Ended September
30 |
||||||||||||||
2002 |
2001 |
2002 |
2001 |
||||||||||||
Numerator: |
|||||||||||||||
Net income available to common shares |
$ |
18.3 |
$ |
3.4 |
|
$ |
54.4 |
|
$ |
13.0 |
| ||||
|
|
|
|
|
|
|
|
|
|
| |||||
Denominator: |
|||||||||||||||
Weighted average common shares outstanding |
|
11,851 |
|
11,739 |
|
|
11,809 |
|
|
11,769 |
| ||||
Dilutive effect of stock options and awards |
|
800 |
|
824 |
|
|
778 |
|
|
746 |
| ||||
|
|
|
|
|
|
|
|
|
|
| |||||
Denominator for diluted earnings per share |
|
12,651 |
|
12,563 |
|
|
12,587 |
|
|
12,515 |
| ||||
|
|
|
|
|
|
|
|
|
|
| |||||
Net income per share |
$ |
1.54 |
$ |
0.29 |
|
$ |
4.60 |
|
$ |
1.10 |
| ||||
|
|
|
|
|
|
|
|
|
|
| |||||
Net income per share, diluted |
$ |
1.44 |
$ |
0.27 |
|
$ |
4.32 |
|
$ |
1.04 |
| ||||
|
|
|
|
|
|
|
|
|
|
| |||||
Earnings before interest, tax, depreciation and amortization (EBITDA) is computed as follows:
|
|||||||||||||||
Operating income |
$ |
25.4 |
$ |
15.1 |
|
$ |
83.8 |
|
$ |
47.2 |
| ||||
Less other expenses |
|
0.8 |
|
(0.7 |
) |
|
(0.7 |
) |
|
(1.3 |
) | ||||
Add depreciation and amortization |
|
6.4 |
|
18.4 |
|
|
19.8 |
|
|
56.5 |
| ||||
|
|
|
|
|
|
|
|
|
|
| |||||
$ |
32.6 |
$ |
32.8 |
|
$ |
102.9 |
|
$ |
102.4 |
| |||||
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30 |
Nine Months Ended September 30 |
|||||||||||||||
2002 |
2001 |
2002 |
2001 |
|||||||||||||
(millions of dollars) |
||||||||||||||||
Net Sales |
||||||||||||||||
TELOngoing |
$ |
66.3 |
|
$ |
59.1 |
|
$ |
188.8 |
|
$ |
202.3 |
| ||||
TELChlorine |
|
3.4 |
|
|
|
|
|
10.9 |
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
69.7 |
|
|
59.1 |
|
|
199.7 |
|
|
202.3 |
| |||||
Specialty Chemicals |
|
46.6 |
|
|
45.8 |
|
|
130.6 |
|
|
107.2 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Total |
$ |
116.3 |
|
$ |
104.9 |
|
$ |
330.3 |
|
$ |
309.5 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Gross Profit |
||||||||||||||||
TELOngoing |
$ |
34.3 |
|
$ |
30.5 |
|
$ |
102.2 |
|
$ |
99.3 |
| ||||
TELChlorine |
|
(0.5 |
) |
|
|
|
|
(0.8 |
) |
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
33.8 |
|
|
30.5 |
|
|
101.4 |
|
|
99.3 |
| |||||
Specialty Chemicals |
|
14.4 |
|
|
16.1 |
|
|
44.3 |
|
|
37.2 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Total |
$ |
48.2 |
|
$ |
46.6 |
|
$ |
145.7 |
|
$ |
136.5 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Operating Income |
||||||||||||||||
TELOngoing |
$ |
29.8 |
|
$ |
14.8 |
|
$ |
89.5 |
|
$ |
51.4 |
| ||||
TELChlorine |
|
(0.5 |
) |
|
|
|
|
(0.8 |
) |
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
29.3 |
|
|
14.8 |
|
|
88.7 |
|
|
51.4 |
| |||||
Specialty Chemicals |
|
3.0 |
|
|
4.2 |
|
|
8.6 |
|
|
8.1 |
| ||||
Corporate Costs |
|
(3.8 |
) |
|
(3.6 |
) |
|
(10.4 |
) |
|
(10.7 |
) | ||||
Restructuring Charge: |
||||||||||||||||
TELOngoing |
|
(0.6 |
) |
|
(0.3 |
) |
|
(0.6 |
) |
|
(1.6 |
) | ||||
TELChlorine |
|
(1.6 |
) |
|
|
|
|
(1.6 |
) |
|
|
| ||||
Specialty Chemicals |
|
(0.9 |
) |
|
|
|
|
(0.9 |
) |
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Total |
$ |
25.4 |
|
$ |
15.1 |
|
$ |
83.8 |
|
$ |
47.2 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30 |
||||||
2002 |
2001 |
|||||
Statutory rate |
35.0 |
% |
35.0 |
% | ||
Increase (decrease) resulting from: |
||||||
Foreign tax rate differential |
(12.0 |
) |
(29.7 |
) | ||
Amortization of goodwill |
|
|
50.6 |
| ||
|
|
|
| |||
23.0 |
% |
55.9 |
% | |||
|
|
|
|
2002 |
2001 |
|||||||
(millions of dollars) |
||||||||
Balance at January 1 |
$ |
39.5 |
|
$ |
35.6 |
| ||
Exchange effect |
|
1.0 |
|
|
(1.0 |
) | ||
Acquired |
|
|
|
|
1.4 |
| ||
Charge for the period |
|
3.1 |
|
|
5.7 |
| ||
Expenditure |
|
(10.6 |
) |
|
(7.1 |
) | ||
|
|
|
|
|
| |||
Balance at September 30 |
|
33.0 |
|
$ |
34.6 |
| ||
|
|
|
|
|
|
1) |
$1.6 million for Chlorine, severance costs for 26 UK employees; |
2) |
$0.6 million for TEL, severance costs for 2 UK employees; and |
3) |
$0.9 million for Specialty Chemicals, severance costs for 11 UK employees. |
At January 1 |
Exchange Effect |
Charge |
Expenditure |
At September 30 | ||||||||||||
(millions of dollars) | ||||||||||||||||
TEL severance |
$ |
7.1 |
$ |
0.1 |
$ |
0.6 |
$ |
(7.0 |
) |
$ |
0.8 | |||||
Chlorine severance |
|
|
|
|
|
1.6 |
|
1.6 | ||||||||
Specialty severance |
|
|
|
|
|
0.9 |
|
(0.2 |
) |
|
0.7 | |||||
|
|
|
|
|
|
|
|
|
|
| ||||||
$ |
7.1 |
$ |
0.1 |
$ |
3.1 |
$ |
(7.2 |
) |
$ |
3.1 | ||||||
|
|
|
|
|
|
|
|
|
|
|
(a) Exhibits | ||
99.2 |
Certificationpursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002Dennis
Kerrison | |
99.3 |
Certificationpursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002Alan
Jarvis | |
(b) Reports on Form 8-K | ||
On August 13, 2002 the Company filed a Form 8-K regarding the adoption of a semi-annual dividend policy. |
Date: November 13, 2002 |
By /s/ Dennis J Kerrison | |
Dennis J Kerrison | ||
President and | ||
Chief Executive Officer | ||
Date: November 13, 2002 |
By /s/ Alan G Jarvis | |
Alan G Jarvis | ||
Vice President and | ||
Chief Financial Officer |
1. |
I have reviewed this quarterly report on Form 10-Q of Octel Corp. |
2. |
Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; |
3. |
Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; |
4. |
The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-14 and 15d-14) for the registrant and we have: |
a) |
designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is
made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; |
b) |
evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly
report (the Evaluation Date); and |
c) |
presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the
Evaluation Date; |
5. |
The registrants other certifying officer and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit
committee of registrants board of directors (or persons performing the equivalent function): |
a) |
all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process,
summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and |
b) |
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and
|
6. |
The registrants other certifying officer and I have indicated in this quarterly report whether or not there were significant changes in internal controls
or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
|
1. |
I have reviewed this quarterly report on Form 10-Q of Octel Corp. |
2. |
Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; |
3. |
Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; |
4. |
The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-14 and 15d-14) for the registrant and we have: |
d) |
designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is
made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; |
e) |
evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly
report (the Evaluation Date); and |
f) |
presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the
Evaluation Date; |
6. |
The registrants other certifying officer and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit
committee of registrants board of directors (or persons performing the equivalent function): |
c) |
all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process,
summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and |
d) |
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and
|
7. |
The registrants other certifying officer and I have indicated in this quarterly report whether or not there were significant changes in internal controls
or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
|